James Mond
2018
In 2018, James Mond earned a total compensation of $1M as Executive Vice President, Chief Scientific Officer and Chief Medical Officer at ADMA Biologics, a 11% decrease compared to previous year.
Compensation breakdown
| Bonus | $117,325 |
|---|---|
| Option Awards | $312,230 |
| Salary | $401,800 |
| Other | $214,094 |
| Total | $1,045,449 |
Mond received $401.8K in salary, accounting for 38% of the total pay in 2018.
Mond also received $117.3K in bonus, $312.2K in option awards and $214.1K in other compensation.
Rankings
In 2018, James Mond's compensation ranked 9,009th out of 14,244 executives tracked by ExecPay. In other words, Mond earned more than 36.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,009 out of 14,244 | 37th |
Division Manufacturing | 3,588 out of 5,765 | 38th |
Major group Chemicals And Allied Products | 1,354 out of 2,128 | 36th |
Industry group Drugs | 1,137 out of 1,817 | 37th |
Industry Biological Products, Except Diagnostic Substances | 216 out of 339 | 36th |
Source: SEC filing on April 24, 2019.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2018.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019